Sitagliptin is an oral medication that treats type 2 diabetes by inhibiting the enzyme dipeptidyl peptidase-4. 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-triazolo[3-a]pyrazine hydrochloride is a chemical intermediate employed to synthesize the drug Sitagliptin phosphate.
3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride
| API Name | Sitagliptin |
|---|---|
| CAS No | 762240-92-6 |
| Molecular Formula | C6H8ClF3N4 |
| Molecular Weight | 228.60 g/mol |
| Synonyms | 3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine;hydrochloride |
Zoho Contact Form
"*" indicates required fields